Hepatitis C Drug Market Worth USD 33.50 Billion by 2022
Zion Market Research has published a new report titled "Hepatitis C Drug Market for Hospitals, Private labs, Physician offices, Public health labs and Blood banks - Global Industry Perspective, Comprehensive Analysis and Forecast, 2016 – 2022." According to the report, the global Hepatitis C drug market accounted for around USD 13.50 billion in 2016 and is expected to reach approximately USD 33.50 by 2022, growing at a CAGR of around 16.0% between 2017 and 2022.
View full press release